Plasma glycocalicin levels are not elevated in patients with a history of transient ischaemic event and are normal in aspirinated normal volunteers

Thrombosis Research

Volumn 81, Issue 3, 1996, Pages 339-343

  Huggan, Paul J ^a   Milne, Alan A ^a   Bessos, Hagop ^b   Atkinson, Anne ^b   Murphy, William G ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b S E Scotland Blood Transfus Serv   (United Kingdom)

Author keywords

aspirin; glycocalicin; transient ischaemic attack

Indexed keywords

ACETYLSALICYLIC ACID; GLYCOCALICIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; ISCHEMIA; MALE; PRIORITY JOURNAL;

EID: 0030007253     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00005-9     Document Type: Article

References (6)

1. STEINBERG, M.H., KELTON, J.G. and COLLER, B.S. Plasma glycocalicin: an aid in the classification of thrombocytopenic disorders. NEJM 317, 1037-1042, 1987.
2. BEER, J.H., BUCH, L. and STEINER, B. Glycocalicin: a new assay - the normal plasma levels and its potential usefulness in selected diseases. Blood 83, 691-702, 1994.
3. BESSOS, H., NISBET, E., SHEPHERD, P., McGILL, A., STEWART, K. and MURPHY, W.G. An assessment of glycocalicin levels in the plasma of various categories of patients. ISTH 73, Abstr, 1995.
4. KUNISHIMA, S., HATTORI, M., KOBAYASHI, S. and HATTORI H. Activation and destruction of platelets in rheumatic heart disease. European Heart Journal 15, 335-338, 1994.
5. BESSOS, H. and MURPHY, W.G. A new competitive binding enzyme-linked immunosorbent assay for glycocalicin in plasma and platelet concentrate supernatants. Thromb Res 59, 497-507, 1990.
6. MICHELSON, A.D. et al. The activation-induced decrease in the platelet surface expression of the glycoprotein 1b-1X complex is reversible. Blood 83, 3562-3573, 1994.